+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Brain Implants Market - Global Forecast 2026-2032- Product Image
Brain Implants Market - Global Forecast 2026-2032- Product Image
Sale

Brain Implants Market - Global Forecast 2026-2032

  • Report

  • 198 Pages
  • July 2026
  • Region: Global
  • 360iResearch™
  • ID: 6083779
UP TO OFF until Dec 31st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Brain Implants Market is projected to reach USD 6.10 Billion in 2026. It is expected to continue growing at a CAGR of 9.43%, reaching USD 10.51 Billion by 2032.

Brain implants are implantable neurotechnology devices designed to interface directly with neural tissue to record, stimulate, modulate, or restore nervous system function. The field spans deep brain stimulation for movement disorders, responsive neurostimulation for epilepsy, cochlear and retinal prosthetic concepts, spinal and cortical interfaces, and emerging brain-computer interface systems for communication and motor control. Demand is being shaped by the documented rise in neurological disease burden, aging populations, improved neurosurgical precision, miniaturized electronics, wireless telemetry, rechargeable power systems, biocompatible materials, and growing clinical evidence for neuromodulation-based treatment pathways. At the same time, the brain implants landscape remains highly regulated because safety, long-term durability, cybersecurity, explainability, informed consent, and post-implant monitoring are central to patient outcomes. Industry participants are increasingly focused on clinically validated indications, human-centered design, reimbursement readiness, real-world evidence generation, and multidisciplinary collaboration across neurology, neurosurgery, psychiatry, rehabilitation, biomedical engineering, and digital health.

Transformative Shifts in the Brain Implants Landscape

The brain implants landscape is shifting from device-centric intervention toward integrated neurotherapeutic ecosystems. Traditional open-loop stimulation is being complemented by closed-loop and adaptive systems that sense neural activity and adjust therapy parameters in response to patient-specific signals. This transition is particularly important in disorders where symptoms fluctuate over time, such as Parkinson’s disease, epilepsy, depression, and chronic pain. Advances in microelectrode arrays, flexible neural probes, hermetic packaging, low-power chips, and wireless data transfer are improving the feasibility of long-term implantation while reducing the burden of clinical programming. Another major shift is the convergence of implantable devices with cloud-connected clinical workflows, remote monitoring, digital biomarkers, and precision imaging. Regulatory agencies are also placing greater emphasis on post-market surveillance, software lifecycle management, cybersecurity controls, usability engineering, and evidence of durable clinical benefit. As brain-computer interfaces move from experimental demonstrations toward functional communication and motor-assist applications, ethical governance around autonomy, neural data privacy, identity, equity of access, and enhancement versus therapy is becoming a defining factor in adoption.

Cumulative Impact of Artificial Intelligence on Brain Implants

Artificial intelligence is increasingly embedded across the brain implants value chain, from signal decoding and adaptive stimulation to surgical planning and longitudinal care optimization. In research and clinical development, machine learning supports the interpretation of complex neural recordings, identification of biomarkers, seizure prediction models, movement-state classification, speech decoding, and patient-specific therapy personalization. In clinical settings, AI-enabled tools can help analyze electrophysiological patterns, imaging data, and symptom diaries to support programming decisions and improve the consistency of therapy management. The most significant cumulative impact lies in closed-loop neuromodulation, where algorithms translate real-time neural signals into dynamic stimulation adjustments, potentially improving therapeutic precision while minimizing adverse effects and energy consumption. However, AI also introduces new requirements for validation, transparency, bias evaluation, data provenance, cybersecurity, human factors testing, and clinician oversight. Because neural data can reveal sensitive information about cognition, emotion, and behavior, AI governance in brain implants must go beyond conventional medical device compliance and address privacy, consent, auditability, and human control throughout the device lifecycle.

Key Regional Insights for Brain Implants

Asia-Pacific is advancing rapidly in brain implants due to expanding neurology infrastructure, large patient populations with neurological disorders, strong public investment in medical technology, and growing clinical research activity in China, Japan, South Korea, India, and Australia. North America remains a highly influential region for implantable neurotechnology because of established neurosurgical centers, early clinical trial activity, recognized investigational device pathways, strong reimbursement structures for approved neuromodulation indications, and mature regulatory frameworks for high-risk medical devices. Latin America is characterized by improving access to advanced neurological care in major urban centers, with Brazil and Mexico playing important roles in specialist treatment adoption, although affordability, reimbursement variability, and uneven distribution of neurosurgical expertise remain practical constraints. Europe benefits from coordinated clinical standards, strong academic neuroscience networks, data protection requirements, and robust medical device regulation, with demand supported by aging demographics and public health systems that evaluate evidence, safety, and cost-effectiveness. The Middle East is investing in specialized hospitals, medical tourism, and advanced neurology services, particularly in Gulf economies, while broader regional adoption depends on workforce development, cross-border clinical partnerships, and sustainable reimbursement. Africa presents long-term need driven by neurological disease burden, epilepsy treatment gaps, stroke rehabilitation needs, and trauma-related conditions, but access to brain implants is limited by specialist availability, infrastructure gaps, device affordability, post-implant follow-up capacity, and competing healthcare priorities.

Key Group Insights for Brain Implants

ASEAN countries are strengthening their role in brain implants through expanding tertiary hospitals, medical device import channels, and growing demand for advanced neurological treatment, although adoption differs substantially between higher-income urban healthcare systems and resource-constrained settings. The GCC is emphasizing premium healthcare infrastructure, international clinical partnerships, and specialist neurology capacity, making it an important group for advanced implantable neurotechnology adoption where reimbursement and centralized procurement support access. The European Union provides one of the most structured environments for brain implants through harmonized medical device regulation, cross-border clinical research networks, data protection requirements, and health technology assessment processes that prioritize safety, clinical evidence, and value-based adoption. BRICS economies combine large neurological patient populations, increasing domestic medical technology capabilities, and expanding clinical research capacity, but they also face heterogeneous regulatory timelines, affordability barriers, and differences in specialist infrastructure. G7 countries remain central to brain implant innovation because of advanced neuroscience research, established regulatory science, high clinical trial activity, specialist hospital networks, and sophisticated reimbursement evaluation, while NATO members indirectly shape the field through defense-funded neurotechnology research, rehabilitation programs for traumatic brain injury, and dual-use governance concerns related to neural interfaces, cybersecurity, human performance applications, and protection of sensitive neural data.

Key Country Insights for Brain Implants

The United States is a leading environment for brain implants due to strong neurosurgical expertise, active investigational device pathways, major academic medical centers, and established use of deep brain stimulation and responsive neurostimulation in approved indications. Canada supports adoption through specialized neurological centers and public healthcare evaluation, with emphasis on evidence-based access and long-term patient management. Mexico is seeing growing demand in metropolitan private healthcare systems, although affordability and specialist concentration influence access. Brazil has one of Latin America’s strongest specialist healthcare bases for advanced neurology, while public-private disparities affect procedure availability. The United Kingdom combines neuroscience research strength with structured clinical evaluation and national health system scrutiny of outcomes and cost-effectiveness. Germany has a mature medical device environment, strong neurosurgical capacity, and broad clinical use of implantable neurostimulation technologies. France benefits from advanced public hospital networks and rigorous clinical assessment of implantable devices, while Italy and Spain show demand supported by aging populations, university hospitals, and neurology referral networks. Russia has specialized neurosurgical capabilities in major centers but faces constraints linked to access, procurement, and regulatory complexity. China is accelerating brain implant research and clinical capacity through government-backed neuroscience initiatives, hospital expansion, and domestic device development. India has significant unmet neurological care needs and growing private-sector adoption of advanced neurosurgery, though affordability and uneven access remain important barriers. Japan’s aging population, high technical standards, and established medical device regulation support continued interest in neuromodulation. Australia combines strong clinical governance with specialized neurology centers, and South Korea is strengthening its role through advanced electronics, hospital technology adoption, and active biomedical engineering research.

Actionable Recommendations for Brain Implant Industry Leaders

Industry leaders should prioritize clinically validated use cases where implantable neurotechnology demonstrates measurable benefit, durable safety, and clear patient selection criteria. Development teams should invest in closed-loop capabilities, low-power electronics, biocompatible materials, secure wireless telemetry, and intuitive clinician programming interfaces while ensuring that device software, AI models, and cybersecurity controls meet lifecycle regulatory expectations. Evidence strategies should include prospective clinical studies, real-world performance monitoring, patient-reported outcomes, explant analysis, adverse event review, and long-term follow-up to support payer confidence and physician adoption. Organizations should also build multidisciplinary partnerships with neurosurgeons, neurologists, psychiatrists, rehabilitation specialists, ethicists, cybersecurity experts, and patient advocacy groups. Commercial strategies should account for reimbursement, implant procedure training, service infrastructure, remote monitoring, battery management, and post-implant support rather than focusing only on device placement. Ethical leadership is essential: neural data governance, informed consent, explainable algorithmic behavior, equitable access, and limits on non-therapeutic enhancement should be addressed early in product design and clinical deployment.

Research Methodology for Brain Implants Analysis

A robust research methodology for brain implants should combine primary and secondary research to validate technology trends, clinical adoption factors, regulatory pathways, and competitive dynamics without relying on unsupported assumptions. Primary inputs should include interviews with neurosurgeons, neurologists, biomedical engineers, hospital procurement specialists, regulatory experts, payers, rehabilitation clinicians, cybersecurity specialists, and patient representatives. Secondary research should draw from peer-reviewed journals, clinical trial registries, regulatory databases, health technology assessment documents, hospital protocol publications, patent filings, public health datasets, adverse event repositories, and standards related to medical devices, cybersecurity, software lifecycle management, and data protection. The analysis should segment evidence by technology type, clinical indication, implant location, end user, procedure workflow, and geography. Data triangulation is essential to distinguish proven clinical use from early-stage experimentation, especially in brain-computer interfaces and AI-enabled neural decoding. Quality controls should include source verification, date relevance checks, exclusion of promotional claims, review of adverse event reporting, and alignment with current regulatory definitions for implantable and software-enabled medical devices.

Conclusion

Brain implants are moving into a new era defined by adaptive neuromodulation, AI-enabled signal interpretation, precision surgery, and stronger integration with digital health infrastructure. The most immediate opportunities remain in clinically validated therapeutic applications, while emerging brain-computer interfaces are expanding the long-term possibilities for communication restoration, motor assistance, and personalized neurorehabilitation. Regional adoption will continue to depend on neurosurgical capacity, reimbursement, regulatory readiness, clinical evidence, post-implant care infrastructure, and patient trust. As innovation accelerates, industry success will be determined not only by engineering performance but also by responsible governance of neural data, transparent AI validation, long-term safety monitoring, and equitable access. Stakeholders that align clinical rigor with ethical design and scalable care models will be best positioned to shape the future of brain implants.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Brain Implants Market, by Implant Type
7.1. Introduction
7.2. Invasive
7.2.1. Cortical Implants
7.2.1.1. Microelectrode Array
7.2.1.2. Utah Array
7.2.2. Deep Brain Stimulation
7.2.2.1. Electrical Stimulation
7.2.2.2. Magnetic Stimulation
7.2.3. Neural Dust
7.2.3.1. Rf Dust
7.2.3.2. Ultrasonic Dust
7.3. Non Invasive
8. Brain Implants Market, by Component
8.1. Introduction
8.2. Implantable Electrodes
8.3. Implantable Pulse Generators
8.4. Neural Processors
8.5. Signal Transmitters
8.6. Receivers
8.7. Implant Leads
8.8. Connectors
9. Brain Implants Market, by Technology
9.1. Introduction
9.2. Brain Computer Interface
9.2.1. Invasive BCI
9.2.2. Non Invasive BCI
9.3. Deep Brain Stimulation
9.3.1. Electrical Stimulation Tech
9.3.2. Magnetic Stimulation Tech
9.4. Neural Dust
9.4.1. Rf Dust Tech
9.4.2. Ultrasonic Dust Tech
9.5. Optogenetics
9.5.1. Channelrhodopsin
9.5.2. Halorhodopsin
10. Brain Implants Market, by Procedure Type
10.1. Introduction
10.2. Implant Replacement Procedures
10.3. Implant Upgrade Procedures
10.4. Revision Procedures
10.5. Implantation Surgery
10.5.1. Open Craniotomy Procedures
10.5.2. Minimally Invasive Procedures
11. Brain Implants Market, by Application
11.1. Introduction
11.2. Consumer
11.2.1. Gaming
11.2.2. Wellness
11.3. Diagnostic
11.3.1. Brain Mapping
11.3.2. Neurological Disorder Monitoring
11.4. Therapeutic
11.4.1. Movement Disorder
11.4.1.1. Epilepsy
11.4.1.2. Parkinsons Disease
11.4.2. Pain Management
11.4.2.1. Chronic Pain
11.4.2.2. Neuropathic Pain
11.4.3. Psychiatry
11.4.3.1. Depression
11.4.3.2. OCD
12. Brain Implants Market, by End User
12.1. Introduction
12.2. Hospitals
12.2.1. Public
12.2.2. Private
12.3. Specialty Neurology Centers
12.4. Neurosurgery Centers
12.5. Research Institutes
12.6. Academic Institutions
12.7. Rehabilitation Centers
13. Brain Implants Market, by Region
13.1. Asia-Pacific
13.2. Europe
13.3. North America
13.4. Latin America
13.5. Africa
13.6. Middle East
14. Brain Implants Market, by Group
14.1. NATO
14.2. G7
14.3. BRICS
14.4. European Union
14.5. ASEAN
14.6. GCC
15. Brain Implants Market, by Country
15.1. China
15.2. United States
15.3. Japan
15.4. India
15.5. Germany
15.6. United Kingdom
15.7. Australia
15.8. France
15.9. South Korea
15.10. Italy
15.11. Canada
15.12. Russia
15.13. Brazil
15.14. Mexico
15.15. Spain
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. FPNV Positioning Matrix, 2025
16.3. Market Concentration Analysis, 2025
16.3.1. Concentration Ratio (CR)
16.3.2. Herfindahl Hirschman Index (HHI)
16.4. Recent Developments & Impact Analysis, 2025
16.5. Product Portfolio Analysis, 2025
16.6. Benchmarking Analysis, 2025
17. Company Profiles
17.1. Abbott Laboratories
17.2. Aleva Neurotherapeutics SA
17.3. Beijing PINS Medical Co., Ltd.
17.4. Blackrock Microsystems LLC
17.5. Boston Scientific Corporation
17.6. BrainCo, Inc.
17.7. Ceribell, Inc.
17.8. ClearPoint Neuro, Inc.
17.9. Cochlear Limited
17.10. Compumedics Limited
17.11. Cyberonics, Inc.
17.12. g.tec medical engineering GmbH
17.13. Inbrain Neuroelectronics S.L.
17.14. Integra LifeSciences Corporation
17.15. LivaNova PLC
17.16. Medtronic PLC
17.17. MicroTransponder, Inc.
17.18. NDI Medical, LLC
17.19. Neuralink Corporation
17.20. Neuronetics, Inc.
17.21. NeuroPace, Inc.
17.22. Neurosoft Bioelectronics SA
17.23. Nihon Kohden Corporation
17.24. Paradromics, Inc.
17.25. Precision Neuroscience Corporation
17.26. Renishaw PLC
17.27. Saluda Medical Pty Ltd.
17.28. Stryker Corporation
17.29. Synchron, Inc.
List of Figures
FIGURE 1. GLOBAL BRAIN IMPLANTS MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL BRAIN IMPLANTS MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL BRAIN IMPLANTS MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL BRAIN IMPLANTS MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL BRAIN IMPLANTS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 6. GLOBAL BRAIN IMPLANTS MARKET SIZE, BY IMPLANT TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL BRAIN IMPLANTS MARKET SIZE, BY IMPLANT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL BRAIN IMPLANTS MARKET SIZE, BY COMPONENT, 2025 VS 2032 (%)
FIGURE 9. GLOBAL BRAIN IMPLANTS MARKET SIZE, BY COMPONENT, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL BRAIN IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
FIGURE 11. GLOBAL BRAIN IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL BRAIN IMPLANTS MARKET SIZE, BY PROCEDURE TYPE, 2025 VS 2032 (%)
FIGURE 13. GLOBAL BRAIN IMPLANTS MARKET SIZE, BY PROCEDURE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL BRAIN IMPLANTS MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 15. GLOBAL BRAIN IMPLANTS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL BRAIN IMPLANTS MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 17. GLOBAL BRAIN IMPLANTS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL BRAIN IMPLANTS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 19. GLOBAL BRAIN IMPLANTS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL BRAIN IMPLANTS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 21. GLOBAL BRAIN IMPLANTS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL BRAIN IMPLANTS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 23. GLOBAL BRAIN IMPLANTS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. GLOBAL BRAIN IMPLANTS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 25. GLOBAL BRAIN IMPLANTS MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL BRAIN IMPLANTS MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL BRAIN IMPLANTS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL BRAIN IMPLANTS MARKET SIZE, BY IMPLANT TYPE, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL INVASIVE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL INVASIVE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL INVASIVE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL CORTICAL IMPLANTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL CORTICAL IMPLANTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL CORTICAL IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL MICROELECTRODE ARRAY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL MICROELECTRODE ARRAY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL MICROELECTRODE ARRAY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL UTAH ARRAY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL UTAH ARRAY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL UTAH ARRAY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL DEEP BRAIN STIMULATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL DEEP BRAIN STIMULATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL DEEP BRAIN STIMULATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL ELECTRICAL STIMULATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL ELECTRICAL STIMULATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL ELECTRICAL STIMULATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL MAGNETIC STIMULATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL MAGNETIC STIMULATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL MAGNETIC STIMULATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL NEURAL DUST MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL NEURAL DUST MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL NEURAL DUST MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL RF DUST MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL RF DUST MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL RF DUST MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL ULTRASONIC DUST MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL ULTRASONIC DUST MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL ULTRASONIC DUST MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL NON INVASIVE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL NON INVASIVE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL NON INVASIVE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL BRAIN IMPLANTS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL IMPLANTABLE ELECTRODES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL IMPLANTABLE ELECTRODES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL IMPLANTABLE ELECTRODES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL IMPLANTABLE PULSE GENERATORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL IMPLANTABLE PULSE GENERATORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL IMPLANTABLE PULSE GENERATORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL NEURAL PROCESSORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL NEURAL PROCESSORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL NEURAL PROCESSORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL SIGNAL TRANSMITTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL SIGNAL TRANSMITTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL SIGNAL TRANSMITTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL RECEIVERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL RECEIVERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL RECEIVERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL IMPLANT LEADS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL IMPLANT LEADS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL IMPLANT LEADS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL CONNECTORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL CONNECTORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL CONNECTORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL BRAIN IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL BRAIN COMPUTER INTERFACE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL BRAIN COMPUTER INTERFACE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL BRAIN COMPUTER INTERFACE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL INVASIVE BCI MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL INVASIVE BCI MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL INVASIVE BCI MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL NON INVASIVE BCI MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL NON INVASIVE BCI MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL NON INVASIVE BCI MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL DEEP BRAIN STIMULATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL DEEP BRAIN STIMULATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL DEEP BRAIN STIMULATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL ELECTRICAL STIMULATION TECH MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL ELECTRICAL STIMULATION TECH MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL ELECTRICAL STIMULATION TECH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL MAGNETIC STIMULATION TECH MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL MAGNETIC STIMULATION TECH MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL MAGNETIC STIMULATION TECH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL NEURAL DUST MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL NEURAL DUST MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL NEURAL DUST MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL RF DUST TECH MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL RF DUST TECH MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL RF DUST TECH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL ULTRASONIC DUST TECH MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL ULTRASONIC DUST TECH MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL ULTRASONIC DUST TECH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL OPTOGENETICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL OPTOGENETICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL OPTOGENETICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL CHANNELRHODOPSIN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL CHANNELRHODOPSIN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL CHANNELRHODOPSIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL HALORHODOPSIN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL HALORHODOPSIN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL HALORHODOPSIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL BRAIN IMPLANTS MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL IMPLANT REPLACEMENT PROCEDURES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL IMPLANT REPLACEMENT PROCEDURES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL IMPLANT REPLACEMENT PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL IMPLANT UPGRADE PROCEDURES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL IMPLANT UPGRADE PROCEDURES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL IMPLANT UPGRADE PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL REVISION PROCEDURES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL REVISION PROCEDURES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL REVISION PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL IMPLANTATION SURGERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL IMPLANTATION SURGERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL IMPLANTATION SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL OPEN CRANIOTOMY PROCEDURES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL OPEN CRANIOTOMY PROCEDURES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL OPEN CRANIOTOMY PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL MINIMALLY INVASIVE PROCEDURES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL MINIMALLY INVASIVE PROCEDURES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL MINIMALLY INVASIVE PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL BRAIN IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL CONSUMER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL CONSUMER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL CONSUMER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL GAMING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL GAMING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL GAMING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL WELLNESS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL WELLNESS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL WELLNESS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL DIAGNOSTIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 126. GLOBAL DIAGNOSTIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 127. GLOBAL DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 128. GLOBAL BRAIN MAPPING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 129. GLOBAL BRAIN MAPPING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 130. GLOBAL BRAIN MAPPING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 131. GLOBAL NEUROLOGICAL DISORDER MONITORING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 132. GLOBAL NEUROLOGICAL DISORDER MONITORING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 133. GLOBAL NEUROLOGICAL DISORDER MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 134. GLOBAL THERAPEUTIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 135. GLOBAL THERAPEUTIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 136. GLOBAL THERAPEUTIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 137. GLOBAL MOVEMENT DISORDER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 138. GLOBAL MOVEMENT DISORDER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 139. GLOBAL MOVEMENT DISORDER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 140. GLOBAL EPILEPSY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 141. GLOBAL EPILEPSY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 142. GLOBAL EPILEPSY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 143. GLOBAL PARKINSONS DISEASE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 144. GLOBAL PARKINSONS DISEASE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 145. GLOBAL PARKINSONS DISEASE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 146. GLOBAL PAIN MANAGEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 147. GLOBAL PAIN MANAGEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 148. GLOBAL PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 149. GLOBAL CHRONIC PAIN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 150. GLOBAL CHRONIC PAIN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 151. GLOBAL CHRONIC PAIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 152. GLOBAL NEUROPATHIC PAIN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 153. GLOBAL NEUROPATHIC PAIN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 154. GLOBAL NEUROPATHIC PAIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 155. GLOBAL PSYCHIATRY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 156. GLOBAL PSYCHIATRY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 157. GLOBAL PSYCHIATRY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 158. GLOBAL DEPRESSION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 159. GLOBAL DEPRESSION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 160. GLOBAL DEPRESSION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 161. GLOBAL OCD MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 162. GLOBAL OCD MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 163. GLOBAL OCD MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 164. GLOBAL BRAIN IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 165. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 166. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 167. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 168. GLOBAL PUBLIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 169. GLOBAL PUBLIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 170. GLOBAL PUBLIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 171. GLOBAL PRIVATE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 172. GLOBAL PRIVATE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 173. GLOBAL PRIVATE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 174. GLOBAL SPECIALTY NEUROLOGY CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 175. GLOBAL SPECIALTY NEUROLOGY CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 176. GLOBAL SPECIALTY NEUROLOGY CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 177. GLOBAL NEUROSURGERY CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 178. GLOBAL NEUROSURGERY CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 179. GLOBAL NEUROSURGERY CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 180. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 181. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 182. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 183. GLOBAL ACADEMIC INSTITUTIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 184. GLOBAL ACADEMIC INSTITUTIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 185. GLOBAL ACADEMIC INSTITUTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 186. GLOBAL REHABILITATION CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 187. GLOBAL REHABILITATION CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 188. GLOBAL REHABILITATION CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 189. GLOBAL BRAIN IMPLANTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 190. ASIA-PACIFIC BRAIN IMPLANTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 191. ASIA-PACIFIC BRAIN IMPLANTS MARKET SIZE, BY IMPLANT TYPE, 2018-2032 (USD MILLION)
TABLE 192. ASIA-PACIFIC BRAIN IMPLANTS MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
TABLE 193. ASIA-PACIFIC BRAIN IMPLANTS MARKET SIZE, BY CORTICAL IMPLANTS, 2018-2032 (USD MILLION)
TABLE 194. ASIA-PACIFIC BRAIN IMPLANTS MARKET SIZE, BY DEEP BRAIN STIMULATION, 2018-2032 (USD MILLION)
TABLE 195. ASIA-PACIFIC BRAIN IMPLANTS MARKET SIZE, BY NEURAL DUST, 2018-2032 (USD MILLION)
TABLE 196. ASIA-PACIFIC BRAIN IMPLANTS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 197. ASIA-PACIFIC BRAIN IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 198. ASIA-PACIFIC BRAIN IMPLANTS MARKET SIZE, BY BRAIN COMPUTER INTERFACE, 2018-2032 (USD MILLION)
TABLE 199. ASIA-PACIFIC BRAIN IMPLANTS MARKET SIZE, BY DEEP BRAIN STIMULATION, 2018-2032 (USD MILLION)
TABLE 200. ASIA-PACIFIC BRAIN IMPLANTS MARKET SIZE, BY NEURAL DUST, 2018-2032 (USD MILLION)
TABLE 201. ASIA-PACIFIC BRAIN IMPLANTS MARKET SIZE, BY OPTOGENETICS, 2018-2032 (USD MILLION)
TABLE 202. ASIA-PACIFIC BRAIN IMPLANTS MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 203. ASIA-PACIFIC BRAIN IMPLANTS MARKET SIZE, BY IMPLANTATION SURGERY, 2018-2032 (USD MILLION)
TABLE 204. ASIA-PACIFIC BRAIN IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 205. ASIA-PACIFIC BRAIN IMPLANTS MARKET SIZE, BY CONSUMER, 2018-2032 (USD MILLION)
TABLE 206. ASIA-PACIFIC BRAIN IMPLANTS MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
TABLE 207. ASIA-PACIFIC BRAIN IMPLANTS MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
TABLE 208. ASIA-PACIFIC BRAIN IMPLANTS MARKET SIZE, BY MOVEMENT DISORDER, 2018-2032 (USD MILLION)
TABLE 209. ASIA-PACIFIC BRAIN IMPLANTS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 210. ASIA-PACIFIC BRAIN IMPLANTS MARKET SIZE, BY PSYCHIATRY, 2018-2032 (USD MILLION)
TABLE 211. ASIA-PACIFIC BRAIN IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 212. ASIA-PACIFIC BRAIN IMPLANTS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 213. EUROPE BRAIN IMPLANTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 214. EUROPE BRAIN IMPLANTS MARKET SIZE, BY IMPLANT TYPE, 2018-2032 (USD MILLION)
TABLE 215. EUROPE BRAIN IMPLANTS MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
TABLE 216. EUROPE BRAIN IMPLANTS MARKET SIZE, BY CORTICAL IMPLANTS, 2018-2032 (USD MILLION)
TABLE 217. EUROPE BRAIN IMPLANTS MARKET SIZE, BY DEEP BRAIN STIMULATION, 2018-2032 (USD MILLION)
TABLE 218. EUROPE BRAIN IMPLANTS MARKET SIZE, BY NEURAL DUST, 2018-2032 (USD MILLION)
TABLE 219. EUROPE BRAIN IMPLANTS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 220. EUROPE BRAIN IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 221. EUROPE BRAIN IMPLANTS MARKET SIZE, BY BRAIN COMPUTER INTERFACE, 2018-2032 (USD MILLION)
TABLE 222. EUROPE BRAIN IMPLANTS MARKET SIZE, BY DEEP BRAIN STIMULATION, 2018-2032 (USD MILLION)
TABLE 223. EUROPE BRAIN IMPLANTS MARKET SIZE, BY NEURAL DUST, 2018-2032 (USD MILLION)
TABLE 224. EUROPE BRAIN IMPLANTS MARKET SIZE, BY OPTOGENETICS, 2018-2032 (USD MILLION)
TABLE 225. EUROPE BRAIN IMPLANTS MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 226. EUROPE BRAIN IMPLANTS MARKET SIZE, BY IMPLANTATION SURGERY, 2018-2032 (USD MILLION)
TABLE 227. EUROPE BRAIN IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 228. EUROPE BRAIN IMPLANTS MARKET SIZE, BY CONSUMER, 2018-2032 (USD MILLION)
TABLE 229. EUROPE BRAIN IMPLANTS MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
TABLE 230. EUROPE BRAIN IMPLANTS MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
TABLE 231. EUROPE BRAIN IMPLANTS MARKET SIZE, BY MOVEMENT DISORDER, 2018-2032 (USD MILLION)
TABLE 232. EUROPE BRAIN IMPLANTS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 233. EUROPE BRAIN IMPLANTS MARKET SIZE, BY PSYCHIATRY, 2018-2032 (USD MILLION)
TABLE 234. EUROPE BRAIN IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 235. EUROPE BRAIN IMPLANTS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 236. NORTH AMERICA BRAIN IMPLANTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 237. NORTH AMERICA BRAIN IMPLANTS MARKET SIZE, BY IMPLANT TYPE, 2018-2032 (USD MILLION)
TABLE 238. NORTH AMERICA BRAIN IMPLANTS MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
TABLE 239. NORTH AMERICA BRAIN IMPLANTS MARKET SIZE, BY CORTICAL IMPLANTS, 2018-2032 (USD MILLION)
TABLE 240. NORTH AMERICA BRAIN IMPLANTS MARKET SIZE, BY DEEP BRAIN STIMULATION, 2018-2032 (USD MILLION)
TABLE 241. NORTH AMERICA BRAIN IMPLANTS MARKET SIZE, BY NEURAL DUST, 2018-2032 (USD MILLION)
TABLE 242. NORTH AMERICA BRAIN IMPLANTS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 243. NORTH AMERICA BRAIN IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 244. NORTH AMERICA BRAIN IMPLANTS MARKET SIZE, BY BRAIN COMPUTER INTERFACE, 2018-2032 (USD MILLION)
TABLE 245. NORTH AMERICA BRAIN IMPLANTS MARKET SIZE, BY DEEP BRAIN STIMULATION, 2018-2032 (USD MILLION)
TABLE 246. NORTH AMERICA BRAIN IMPLANTS MARKET SIZE, BY NEURAL DUST, 2018-2032 (USD MILLION)
TABLE 247. NORTH AMERICA BRAIN IMPLANTS MARKET SIZE, BY OPTOGENETICS, 2018-2032 (USD MILLION)
TABLE 248. NORTH AMERICA BRAIN IMPLANTS MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 249. NORTH AMERICA BRAIN IMPLANTS MARKET SIZE, BY IMPLANTATION SURGERY, 2018-2032 (USD MILLION)
TABLE 250. NORTH AMERICA BRAIN IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 251. NORTH AMERICA BRAIN IMPLANTS MARKET SIZE, BY CONSUMER, 2018-2032 (USD MILLION)
TABLE 252. NORTH AMERICA BRAIN IMPLANTS MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
TABLE 253. NORTH AMERICA BRAIN IMPLANTS MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
TABLE 254. NORTH AMERICA BRAIN IMPLANTS MARKET SIZE, BY MOVEMENT DISORDER, 2018-2032 (USD MILLION)
TABLE 255. NORTH AMERICA BRAIN IMPLANTS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 256. NORTH AMERICA BRAIN IMPLANTS MARKET SIZE, BY PSYCHIATRY, 2018-2032 (USD MILLION)
TABLE 257. NORTH AMERICA BRAIN IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 258. NORTH AMERICA BRAIN IMPLANTS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 259. LATIN AMERICA BRAIN IMPLANTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 260. LATIN AMERICA BRAIN IMPLANTS MARKET SIZE, BY IMPLANT TYPE, 2018-2032 (USD MILLION)
TABLE 261. LATIN AMERICA BRAIN IMPLANTS MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
TABLE 262. LATIN AMERICA BRAIN IMPLANTS MARKET SIZE, BY CORTICAL IMPLANTS, 2018-2032 (USD MILLION)
TABLE 263. LATIN AMERICA BRAIN IMPLANTS MARKET SIZE, BY DEEP BRAIN STIMULATION, 2018-2032 (USD MILLION)
TABLE 264. LATIN AMERICA BRAIN IMPLANTS MARKET SIZE, BY NEURAL DUST, 2018-2032 (USD MILLION)
TABLE 265. LATIN AMERICA BRAIN IMPLANTS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 266. LATIN AMERICA BRAIN IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 267. LATIN AMERICA BRAIN IMPLANTS MARKET SIZE, BY BRAIN COMPUTER INTERFACE, 2018-2032 (USD MILLION)
TABLE 268. LATIN AMERICA BRAIN IMPLANTS MARKET SIZE, BY DEEP BRAIN STIMULATION, 2018-2032 (USD MILLION)
TABLE 269. LATIN AMERICA BRAIN IMPLANTS MARKET SIZE, BY NEURAL DUST, 2018-2032 (USD MILLION)
TABLE 270. LATIN AMERICA BRAIN IMPLANTS MARKET SIZE, BY OPTOGENETICS, 2018-2032 (USD MILLION)
TABLE 271. LATIN AMERICA BRAIN IMPLANTS MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 272. LATIN AMERICA BRAIN IMPLANTS MARKET SIZE, BY IMPLANTATION SURGERY, 2018-2032 (USD MILLION)
TABLE 273. LATIN AMERICA BRAIN IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 274. LATIN AMERICA BRAIN IMPLANTS MARKET SIZE, BY CONSUMER, 2018-2032 (USD MILLION)
TABLE 275. LATIN AMERICA BRAIN IMPLANTS MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
TABLE 276. LATIN AMERICA BRAIN IMPLANTS MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
TABLE 277. LATIN AMERICA BRAIN IMPLANTS MARKET SIZE, BY MOVEMENT DISORDER, 2018-2032 (USD MILLION)
TABLE 278. LATIN AMERICA BRAIN IMPLANTS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 279. LATIN AMERICA BRAIN IMPLANTS MARKET SIZE, BY PSYCHIATRY, 2018-2032 (USD MILLION)
TABLE 280. LATIN AMERICA BRAIN IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 281. LATIN AMERICA BRAIN IMPLANTS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 282. AFRICA BRAIN IMPLANTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 283. AFRICA BRAIN IMPLANTS MARKET SIZE, BY IMPLANT TYPE, 2018-2032 (USD MILLION)
TABLE 284. AFRICA BRAIN IMPLANTS MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
TABLE 285. AFRICA BRAIN IMPLANTS MARKET SIZE, BY CORTICAL IMPLANTS, 2018-2032 (USD MILLION)
TABLE 286. AFRICA BRAIN IMPLANTS MARKET SIZE, BY DEEP BRAIN STIMULATION, 2018-2032 (USD MILLION)
TABLE 287. AFRICA BRAIN IMPLANTS MARKET SIZE, BY NEURAL DUST, 2018-2032 (USD MILLION)
TABLE 288. AFRICA BRAIN IMPLANTS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 289. AFRICA BRAIN IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 290. AFRICA BRAIN IMPLANTS MARKET SIZE, BY BRAIN COMPUTER INTERFACE, 2018-2032 (USD MILLION)
TABLE 291. AFRICA BRAIN IMPLANTS MARKET SIZE, BY DEEP BRAIN STIMULATION, 2018-2032 (USD MILLION)
TABLE 292. AFRICA BRAIN IMPLANTS MARKET SIZE, BY NEURAL DUST, 2018-2032 (USD MILLION)
TABLE 293. AFRICA BRAIN IMPLANTS MARKET SIZE, BY OPTOGENETICS, 2018-2032 (USD MILLION)
TABLE 294. AFRICA BRAIN IMPLANTS MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 295. AFRICA BRAIN IMPLANTS MARKET SIZE, BY IMPLANTATION SURGERY, 2018-2032 (USD MILLION)
TABLE 296. AFRICA BRAIN IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 297. AFRICA BRAIN IMPLANTS MARKET SIZE, BY CONSUMER, 2018-2032 (USD MILLION)
TABLE 298. AFRICA BRAIN IMPLANTS MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
TABLE 299. AFRICA BRAIN IMPLANTS MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
TABLE 300. AFRICA BRAIN IMPLANTS MARKET SIZE, BY MOVEMENT DISORDER, 2018-2032 (USD MILLION)
TABLE 301. AFRICA BRAIN IMPLANTS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 302. AFRICA BRAIN IMPLANTS MARKET SIZE, BY PSYCHIATRY, 2018-2032 (USD MILLION)
TABLE 303. AFRICA BRAIN IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 304. AFRICA BRAIN IMPLANTS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 305. MIDDLE EAST BRAIN IMPLANTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 306. MIDDLE EAST BRAIN IMPLANTS MARKET SIZE, BY IMPLANT TYPE, 2018-2032 (USD MILLION)
TABLE 307. MIDDLE EAST BRAIN IMPLANTS MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
TABLE 308. MIDDLE EAST BRAIN IMPLANTS MARKET SIZE, BY CORTICAL IMPLANTS, 2018-2032 (USD MILLION)
TABLE 309. MIDDLE EAST BRAIN IMPLANTS MARKET SIZE, BY DEEP BRAIN STIMULATION, 2018-2032 (USD MILLION)
TABLE 310. MIDDLE EAST BRAIN IMPLANTS MARKET SIZE, BY NEURAL DUST, 2018-2032 (USD MILLION)
TABLE 311. MIDDLE EAST BRAIN IMPLANTS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 312. MIDDLE EAST BRAIN IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 313. MIDDLE EAST BRAIN IMPLANTS MARKET SIZE, BY BRAIN COMPUTER INTERFACE, 2018-2032 (USD MILLION)
TABLE 314. MIDDLE EAST BRAIN IMPLANTS MARKET SIZE, BY DEEP BRAIN STIMULATION, 2018-2032 (USD MILLION)
TABLE 315. MIDDLE EAST BRAIN IMPLANTS MARKET SIZE, BY NEURAL DUST, 2018-2032 (USD MILLION)
TABLE 316. MIDDLE EAST BRAIN IMPLANTS MARKET SIZE, BY OPTOGENETICS, 2018-2032 (USD MILLION)
TABLE 317. MIDDLE EAST BRAIN IMPLANTS MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 318. MIDDLE EAST BRAIN IMPLANTS MARKET SIZE, BY IMPLANTATION SURGERY, 2018-2032 (USD MILLION)
TABLE 319. MIDDLE EAST BRAIN IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 320. MIDDLE EAST BRAIN IMPLANTS MARKET SIZE, BY CONSUMER, 2018-2032 (USD MILLION)
TABLE 321. MIDDLE EAST BRAIN IMPLANTS MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
TABLE 322. MIDDLE EAST BRAIN IMPLANTS MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
TABLE 323. MIDDLE EAST BRAIN IMPLANTS MARKET SIZE, BY MOVEMENT DISORDER, 2018-2032 (USD MILLION)
TABLE 324. MIDDLE EAST BRAIN IMPLANTS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 325. MIDDLE EAST BRAIN IMPLANTS MARKET SIZE, BY PSYCHIATRY, 2018-2032 (USD MILLION)
TABLE 326. MIDDLE EAST BRAIN IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 327. MIDDLE EAST BRAIN IMPLANTS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 328. GLOBAL BRAIN IMPLANTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 329. NATO BRAIN IMPLANTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 330. NATO BRAIN IMPLANTS MARKET SIZE, BY IMPLANT TYPE, 2018-2032 (USD MILLION)
TABLE 331. NATO BRAIN IMPLANTS MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
TABLE 332. NATO BRAIN IMPLANTS MARKET SIZE, BY CORTICAL IMPLANTS, 2018-2032 (USD MILLION)
TABLE 333. NATO BRAIN IMPLANTS MARKET SIZE, BY DEEP BRAIN STIMULATION, 2018-2032 (USD MILLION)
TABLE 334. NATO BRAIN IMPLANTS MARKET SIZE, BY NEURAL DUST, 2018-2032 (USD MILLION)
TABLE 335. NATO BRAIN IMPLANTS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 336. NATO BRAIN IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 337. NATO BRAIN IMPLANTS MARKET SIZE, BY BRAIN COMPUTER INTERFACE, 2018-2032 (USD MILLION)
TABLE 338. NATO BRAIN IMPLANTS MARKET SIZE, BY DEEP BRAIN STIMULATION, 2018-2032 (USD MILLION)
TABLE 339. NATO BRAIN IMPLANTS MARKET SIZE, BY NEURAL DUST, 2018-2032 (USD MILLION)
TABLE 340. NATO BRAIN IMPLANTS MARKET SIZE, BY OPTOGENETICS, 2018-2032 (USD MILLION)
TABLE 341. NATO BRAIN IMPLANTS MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 342. NATO BRAIN IMPLANTS MARKET SIZE, BY IMPLANTATION SURGERY, 2018-2032 (USD MILLION)
TABLE 343. NATO BRAIN IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 344. NATO BRAIN IMPLANTS MARKET SIZE, BY CONSUMER, 2018-2032 (USD MILLION)
TABLE 345. NATO BRAIN IMPLANTS MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
TABLE 346. NATO BRAIN IMPLANTS MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
TABLE 347. NATO BRAIN IMPLANTS MARKET SIZE, BY MOVEMENT DISORDER, 2018-2032 (USD MILLION)
TABLE 348. NATO BRAIN IMPLANTS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 349. NATO BRAIN IMPLANTS MARKET SIZE, BY PSYCHIATRY, 2018-2032 (USD MILLION)
TABLE 350. NATO BRAIN IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 351. NATO BRAIN IMPLANTS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 352. G7 BRAIN IMPLANTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 353. G7 BRAIN IMPLANTS MARKET SIZE, BY IMPLANT TYPE, 2018-2032 (USD MILLION)
TABLE 354. G7 BRAIN IMPLANTS MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
TABLE 355. G7 BRAIN IMPLANTS MARKET SIZE, BY CORTICAL IMPLANTS, 2018-2032 (USD MILLION)
TABLE 356. G7 BRAIN IMPLANTS MARKET SIZE, BY DEEP BRAIN STIMULATION, 2018-2032 (USD MILLION)
TABLE 357. G7 BRAIN IMPLANTS MARKET SIZE, BY NEURAL DUST, 2018-2032 (USD MILLION)
TABLE 358. G7 BRAIN IMPLANTS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 359. G7 BRAIN IMPLANTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 360. G7 BRAIN IMPLANTS MARKET SIZE, BY BRAIN COMPUTER INTERFACE, 2018-2032 (USD MILLION)
TABLE 361. G7 BRAIN IMPLANTS MARKET SIZE, BY DEEP BRAIN STIMULATION, 2018-2032 (USD MILLION)
TABLE 362. G7 BRAIN IMPLANTS MARKET SIZE, BY NEURAL DUST, 2018-2032 (USD MILLION)
TABLE 363. G7 BRAIN IMPLANTS MARKET SIZE, BY OPTOGENETICS, 2018-2032 (USD MILLION)
TABLE 364. G7 BRAIN IMPLANTS MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 365. G7 BRAIN IMPLANTS MARKET SIZE, BY IMPLANTATION SURGERY, 2018-2032 (USD MILLION)
TABLE 366. G7 BRAIN IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 367. G7 BRAIN IMPLANTS MARKET SIZE, BY CONSUMER, 2018-2032 (USD MILLION)
TABLE 368. G7 BRAIN IMPLANTS MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
TABLE 369. G7 BRAIN IMPLANTS MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
TABLE 370. G7 BRAIN IMPLANTS MARKET SIZE, BY MOVEMENT DISORDER, 2018-2032 (USD MILLION)
TABLE 371. G7 BRAIN IMPLANTS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 372. G7 BRAIN IMPLANTS MARKET SIZE, BY PSYCHIATRY, 2018-2032 (USD MILLION)
TABLE 373. G7 BRAIN IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 374. G7 BRAIN IMPLANTS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 375. BRICS BRAIN IMPLANTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 376. BRICS BRAIN IMPLANTS MARKET SIZE, BY IMPLANT TYPE, 2018-2032 (USD MILLION)
TABLE 377. BRICS BRAIN IMPLANTS MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
TABLE 378. BRICS BRAIN IMPLANTS MARKET SIZE, BY CORTICAL IMPLANTS, 2018-2032 (USD MILLION)
TABLE 379. BRICS BRAIN IMPLANTS MARKET SIZE, BY DEEP BRAIN STIMULATION, 2018-2032 (USD MILLION)
TABLE 380. BRICS BRAIN IMPLANTS MARKET SIZE, BY N

Companies Mentioned

  • Abbott Laboratories
  • Aleva Neurotherapeutics SA
  • Beijing PINS Medical Co., Ltd.
  • Blackrock Microsystems LLC
  • Boston Scientific Corporation
  • BrainCo, Inc.
  • Ceribell, Inc.
  • ClearPoint Neuro, Inc.
  • Cochlear Limited
  • Compumedics Limited
  • Cyberonics, Inc.
  • g.tec medical engineering GmbH
  • Inbrain Neuroelectronics S.L.
  • Integra LifeSciences Corporation
  • LivaNova PLC
  • Medtronic PLC
  • MicroTransponder, Inc.
  • NDI Medical, LLC
  • Neuralink Corporation
  • Neuronetics, Inc.
  • NeuroPace, Inc.
  • Neurosoft Bioelectronics SA
  • Nihon Kohden Corporation
  • Paradromics, Inc.
  • Precision Neuroscience Corporation
  • Renishaw PLC
  • Saluda Medical Pty Ltd.
  • Stryker Corporation
  • Synchron, Inc.

Table Information

Report AttributeDetails
No. of Pages198
PublishedJuly 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 6.1 Billion
Forecasted Market Value ( USD ) by 2032 $ 10.51 Billion
Compound Annual Growth Rate9.4%
Regions CoveredGlobal
No. of Companies Mentioned29

Related Topics

Related Reports

Brain Implants - Global Strategic Business Report - Product Image

Brain Implants - Global Strategic Business Report

  • Report
  • 224 Pages
  • Global
From
Brain Implants Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031 - Product Image

Brain Implants Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

  • Report
  • 180 Pages
  • Global
From
Brain Implants Market Insights, Competitive Landscape, and Market Forecast - 2033 - Product Image

Brain Implants Market Insights, Competitive Landscape, and Market Forecast - 2033

  • Report
  • 197 Pages
  • Global
From
Neurosurgery Devices Market - Global Forecast 2026-2032 - Product Image

Neurosurgery Devices Market - Global Forecast 2026-2032

  • Report
  • 194 Pages
  • Global
From
Neuroprosthetics - Global Strategic Business Report - Product Image

Neuroprosthetics - Global Strategic Business Report

  • Report
  • 180 Pages
  • Global
From

About the Brain Implant Market

Brain implants, also known as neural implants, are devices that are surgically implanted into the brain to monitor, stimulate, or modify brain activity. They are used in the field of neurology to treat a variety of neurological disorders, such as Parkinson's disease, epilepsy, and depression. Brain implants can be used to monitor brain activity, to stimulate the brain to produce certain signals, or to modify the brain's activity. Brain implants are typically made of biocompatible materials, such as titanium, and are designed to be minimally invasive. They are connected to a computer system, which can be used to monitor and control the implant's activity. The implant is typically powered by a battery, which is implanted along with the device. Brain implants are used in a variety of medical applications, including the treatment of neurological disorders, the control of seizures, and the stimulation of the brain to improve cognitive function. They are also used in research to study the brain and its functions. Some of the companies in the brain implant market include Medtronic, Abbott, Boston Scientific, St. Jude Medical, and NeuroPace. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.